Buscar
Congreso SOLACI

Búsqueda de: valve

Si no está conforme con los resultados, inténtelo de nuevamente.
Structural Heart Disease

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

The prospective, multicenter SUMMIT-MAC study evaluated the safety and efficacy of transcatheter mitral valve replacement (TMVR) using...
Dr. Juan Manuel Pérez -
Ir
Structural Heart Disease

TCT 2025 | PREVUE-VALVE: Prevalence of Valvular Heart Disease in Elderly US Patients

The PREVUE-VALVE study was designed to determine the true prevalence and demographic determinants of valvular heart disease...
Dr. Juan Manuel Pérez -
Ir
Mitral valve

TCT 2025 | Transcatheter Mitral Valve Replacement with SAPIEN M3: ENCIRCLE 1-Year Outcomes

Transcatheter mitral valve replacement (TMVR) is an emerging option for patients with symptomatic mitral regurgitation (MR) who...
Dr. Juan Manuel Pérez -
Ir
Other

TRAVEL Trial One-Year Outcomes: Transcatheter Treatment of the Tricuspid Valve

Tricuspid regurgitation (TR) has been associated with increased mortality and progressive functional deterioration. Even though the current...
Dr. Andrés Rodríguez -
Ir
Structural heart disease

When Is the Optimal Time for Aortic Valve Replacement? Impact of Acute Valvular Syndrome on Outcomes and Costs

According to the clinical presentation before aortic valve replacement (AVR), a new classification has recently been proposed:...
Dr. Juan Manuel Pérez -
Ir
Structural heart disease

In Hospital Complications after Transcatheter Aortic Valve Replacement in Bicuspid vs. Tricuspid Aortic Valves: A Retrospective Cohort Study

Courtesy of Dr. Juan Manuel Pérez.  Bicuspid aortic valves (BAV), present in 0,5 to 2% of the population,...
Dr. Juan Manuel Pérez -
Ir
Structural heart disease

Should Early Aortic Valve Replacement Be Indicated in Asymptomatic Severe Aortic Stenosis?

A Meta-Analysis of Randomized Clinical Trials. The management of aortic stenosis in asymptomatic patients remains a matter of...
Dr. Juan Manuel Pérez -
Ir
Structural heart disease

Predilatation in Self-Expanding Valves

TAVI has become the treatment of choice in specific scenarios. However, predilatation (PRD) remains a matter of...
Dr. Carlos Fava -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad